Regenerex Pharma (RGPX) Net Margin (2014 - 2020)
Regenerex Pharma (RGPX) reported Net Margin of 14063.54% for Q4 2020, down 1282739.0% year-over-year from N/an in Q1 2020, and up 25.87% quarter-over-quarter from 18970.83% in Q3 2020.
Regenerex Pharma (RGPX) Net Margin (2014 - 2020) Analysis & Trends
Regenerex Pharma (RGPX) has 3 years of Net Margin data on file, last reported at 14063.54% in Q4 2020.
- Net Margin for Q4 2020 came in at 14063.54%, down 1282739.0% year-over-year; the trailing twelve-month figure through Dec 2020 was 6789.2% (changed N/A YoY), and the FY2020 annual result was 3330.98%, changed N/A from the prior year.
- Net Margin advanced to 14063.54% in Q4 2020 per RGPX's latest filing, from 18970.83% in the prior quarter.
- Over five years, Net Margin peaked at 1236.15% in Q4 2019 and troughed at 25228.57% in Q2 2020.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -14,063.54% |
| Sep 30, 2020 | -18,970.83% |
| Jun 30, 2020 | -25,228.57% |
| Mar 31, 2020 | -2,308.64% |
| Dec 31, 2019 | -1,236.15% |
| Aug 31, 2014 | -644.80% |